Histological and molecular evaluation of iron as degradable medical implant material in a murine animal model

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 11, 2012, Pages 2881-2889

  Mueller, Peter P ^a   Arnold, Sylvia ^b   Badar, Muhammad ^a   Bormann, Dirk ^c   Bach, Friedrich Wilhelm ^c   Drynda, Andreas ^d   Meyer Lindenberg, Andrea ^b   Hauser, Hansjörg ^a   Peuster, Matthias ^d  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Biodegradation; Coil; Implant material; Iron; Mouse model

Indexed keywords

BIODEGRADATION; DEGRADATION; GENE EXPRESSION; MAMMALS; METAL IONS;

ANIMAL MODEL; CELLULAR RESPONSE; COIL; DEGRADATION PRODUCTS; GENE EXPRESSION DATA; HISTOLOGICAL ANALYSIS; IMPLANT MATERIALS; IMPLANTATION SITES; IN-VIVO; INDIVIDUAL CELLS; INFLAMMATORY REACTION; IRON IONS; MEDICAL IMPLANTS; MICROARRAY ANALYSIS; MOUSE MODELS; SMALL ANIMAL MODEL; TIME-PERIODS;

IRON;

IRON;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; CONTROLLED STUDY; FEMALE; FOIL; GENE CONTROL; GENE EXPRESSION; GUIDE WIRE; HISTOLOGY; IMPLANT; INTRAVENOUS CATHETER; METAL IMPLANTATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; TISSUE INTERACTION; WOUND HEALING;

EID: 84869096077     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34223     Document Type: Article

References (56)

1. Peuster M, Fink C, von Schnakenburg C, Hausdorf G. Dissolution of tungsten coils does not produce systemic toxicity, but leads to elevated levels of tungsten in the serum and recanalization of the previously occluded vessel. Cardiol Young 2002;12:229-235. (Pubitemid 41238835)
2. Gotman I. Characteristics of metals used in implants. J Endourol 1997;11:383-389. (Pubitemid 28021408)
3. McMahon CJ, El-Said HG, Grifka RG, Fraley JK, Nihill MR, Mullins CE. Redilation of endovascular stents in congenital heart disease: Factors implicated in the development of restenosis and neointimal proliferation. J Am Coll Cardiol 2001;38:521-526. (Pubitemid 32721783)
4. Duke C, Rosenthal E, Qureshi SA. The efficacy and safety of stent redilatation in congenital heart disease. Heart 2003;89:905-912. (Pubitemid 36920818)
5. Artang R, Dieter RS. Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries. Am J Cardiol 2007;99:1039-1043. (Pubitemid 46560471)
6. Anis RR, Karsch KR, Oberhoff M. An update on clinical and pharmacological aspects of drug-eluting stents. Cardiovasc Hematol Disord Drug Targets 2006;6:245-255. (Pubitemid 44890587)
7. Balla S, Aggarwal K, Nistala R. Bioabsorbable coronary stents-Are these the next big thing in coronary angioplasty? Recent Pat Cardiovasc Drug Discov 2010;5:86-90.
8. Waksman R. Biodegradable stents: They do their job and disappear. J Invasive Cardiol 2006;18:70-74.
9. Peuster M, Kaese V, Wuensch G, Wuebbolt P, Niemeyer M, Boekenkamp R, Fink C, Haferkamp H, Hausdorf G. Dissolution of tungsten coils leads to device failure after transcatheter embolisation of pathologic vessels. Heart 2001;85:703-704. (Pubitemid 32973473)
10. Nakatani M, Takeyama Y, Shibata M, Yorozuya M, Suzuki H, Koba S, Katagiri T. Mechanisms of restenosis after coronary intervention: Difference between plain old balloon angioplasty and stenting. Cardiovasc Pathol 2003;12:40-48. (Pubitemid 36206511)
11. Kampmann C, Brzezinska R, Abidini M, Wenzel A, Wippermann CF, Habermehl P, Knuf M, Schumacher R. Biodegradation of tungsten embolisation coils used in children. Pediatr Radiol 2002;32:839-843. (Pubitemid 36097139)
12. Peuster M, Wohlsein P, Brugmann M, Ehlerding M, Seidler K, Fink C, Brauer H, Fischer A, Hausdorf G. A novel approach to temporary stenting: Degradable cardiovascular stents produced from corrodible metal-Results 6-18 months after implantation into New Zealand white rabbits. Heart 2001;86:563-569. (Pubitemid 32999872)
13. Di Mario C, Griffiths H, Goktekin O, Peeters N, Verbist J, Bosiers M, Deloose K, Heublein B, Rohde R, Kasese V, Ilsley C, Erbel R. Drug-eluting bioabsorbable magnesium stent. J Interv Cardiol 2004;17:391-395. (Pubitemid 39552594)
14. Popp T, Rzany A, Hensel B, Schaldach M. Biodegradierbare Metallstents aus Zinklegierungen. Biomedizinische Technik 2001;46:246-247.
15. Peuster M, Beerbaum P, Bach FW, Hauser H. Are resorbable implants about to become a reality? Cardiol Young 2006;16:107-116. (Pubitemid 44269389)
16. Peuster M, Fink C, von Schnakenburg C. Biocompatibility of corroding tungsten coils: In vitro assessment of degradation kinetics and cytotoxicity on human cells. Biomaterials 2003;24:4057-4061. (Pubitemid 36794408)
17. Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A. Biocorrosion of magnesium alloys: A new principle in cardiovascular implant technology? Heart 2003;89:651-656. (Pubitemid 36606211)
18. Witte F, Reifenrath J, Müller PP, Crostack H-A, Nellesen J, Bach FW, Bormann D, Rudert M. Cartilage repair on magnesium scaffolds used as a subchondral bone replacement. Mat.-wiss u Werkstofftech 2006;37:504-508. (Pubitemid 44012814)
19. Witte F, Fischer J, Nellesen J, Crostack HA, Kaese V, Pisch A, Beckmann F, Windhagen H. In vitro and in vivo corrosion measurements of magnesium alloys. Biomaterials 2006;27:1013-1018. (Pubitemid 41566693)
20. Zartner P, Cesnjevar R, Singer H, Weyand M. First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby. Catheter Cardiovasc Interv 2005;66:590-594. (Pubitemid 41779033)
21. van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DR Jr, Ellis SG, Topol EJ. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996;94:1690-1697. (Pubitemid 26320276)
22. Vogt F, Stein A, Rettemeier G, Krott N, Hoffmann R, vom Dahl J, Bosserhoff AK, Michaeli W, Hanrath P, Weber C, Blindt R. Longterm assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent. Eur Heart J 2004;25:1330-1340. (Pubitemid 38998510)
23. Sigler M, Paul T, Grabitz RG. Biocompatibility screening in cardiovascular implants. Z Kardiol 2005;94:383-391. (Pubitemid 40921966)
24. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, Komori H, Tsuji T, Motohara S, Uehata H. Initial and 6-month results of biodegradable poly-L-lactic acid coronary stents in humans. Circulation 2000;102:399-404. (Pubitemid 30490677)
25. Venkatraman S, Poh TL, Vinalia T, Mak KH, Boey F. Collapse pressures of biodegradable stents. Biomaterials 2003;24:2105-2111. (Pubitemid 36298782)
26. Peuster M, Hesse C, Schloo T, Fink C, Beerbaum P, von Schnakenburg C. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta. Biomaterials 2006;27:4955-4962. (Pubitemid 43866928)
27. Zhang AS, Enns CA. Iron homeostasis: Recently identified proteins provide insight into novel control mechanisms. J Biol Chem 2009;284:711-715.
28. Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: Molecular control of mammalian iron metabolism. Cell 2004;117:285-297. (Pubitemid 38534536)
29. Hermawan H, Moravej M, Dubé D, Fiset M, Mantovani D. Degradation behaviour of metallic biomaterials for degradable stents. Adv Mater Res 15;15-17:113-118.
30. Abasht B, Kaiser MG, van der Poel J, Lamont SJ. Genetic lines differ in Toll-like receptor gene expression in spleens of chicks inoculated with Salmonella enterica serovar Enteritidis. Poult Sci 2009;88:744-749.
31. Mueller PP, May T, Perz A, Hauser H, Peuster M. Control of smooth muscle cell proliferation by ferrous iron. Biomaterials 2006;27:2193-2200. (Pubitemid 41774531)
32. Hermawan H, Dubé D, Mantovani D. Degradable metallic biomaterials: Design and development of Fe-Mn alloys for stents. J Biomed Mater Res A 2010;93:1-11.
33. Erne P, Schier M, Resink TJ. The road to bioabsorbable stents: Reaching clinical reality? Cardiovasc Intervent Radiol 2006;29:11-16. (Pubitemid 43128134)
34. Griffiths H, Peeters P, Verbist J, Bosiers M, Deloose K, Heublein B, Rohde R, Kasese V, Ilsley C, di Mario C. Future devices: Bioabsorbable stents. Br J Cardiol 2004;11:80-84.
35. Schwartz RS, Edelman ER, Carter A, Chronos NA, Rogers C, Robinson KA, Waksman R, Machan L, Weinberger J, Wilensky RL, Goode JL, Hottenstein OD, Zuckerman BD, Virmani R. Preclinical evaluation of drug-eluting stents for peripheral applications: Recommendations from an expert consensus group. Circulation 2004;110:2498-2505. (Pubitemid 39407359)
36. Richardson KC, Jarett L, Finke EH. Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Stain Technol 1960;35:313-323.
37. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4:P3.
38. de Hoon MJ, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics 2004;20:1453-1454. (Pubitemid 38931415)
39. Rey S, Semenza GL. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 2010;86:236-242.
40. Dvorak HF. Angiogenesis: Update 2005. J Thromb Haemost 2005;3:1835-1842. (Pubitemid 41716570)
41. Drynda A, Hoehn R, Peuster M. Influence of Fe (II) and Fe (III) on the expression of genes related to cholesterol and fatty acid metabolism in human vascular smooth muscle cells. J Mater Sci Mater Med 2010;21:1655-1663.
42. Chanakira A, Dutta R, Charboneau R, Barke R, Santilli SM, Roy S. Hypoxia differentially regulates arterial and venous smooth muscle cell proliferation via PDGFRbeta and VEGFR-2 expression. Am J Physiol Heart Circ Physiol 2012;302:H1173-H1184.
43. Pierson D, Edick J, Tauscher A, Pokorney E, Bowen P, Gelbaugh J, Stinson J, Getty H, Lee CH, Drelich J, Goldman J. A simplified in vivo approach for evaluating the bioabsorbable behavior of candidate stent materials. J Biomed Mater Res Part B 2012;100B: 58-67.
44. Hara H, Nakamura M, Palmaz JC, Schwartz RS. Role of stent design and coatings on restenosis and thrombosis. Adv Drug Deliv Rev 2006;58:377-386. (Pubitemid 43816740)
45. Whittaker DR, Fillinger MF. The engineering of endovascular stent technology: A review. Vasc Endovascular Surg 2006;40:85-94. (Pubitemid 44439942)
46. Sullivan TM, Ainsworth SD, Langan EM, Taylor S, Snyder B, Cull D, Youkey J, Laberge M. Effect of endovascular stent strut geometry on vascular injury, myointimal hyperplasia, and restenosis. J Vasc Surg 2002;36:143-149. (Pubitemid 41122903)
47. Hermawan H, Dubé D, Mantovani D. Development of degradable Fe-35Mn alloy for biomedical application. Adv Mater Res 2007;15-17:107-112.
48. Hermawan H, Purnama A, Dubé D, Couet J, Mantovani D. Fe-Mn alloys for metallic biodegradable stents: Degradation and cell viability studies. Acta Biomaterialia 2010;6:1852-1860.
49. Gaber Y. [Grenade splinter injury simulating thrombophlebitis]. Vasa 2003;32:40-42. (Pubitemid 36286280)
50. Ghislain PD. Spontaneous extrusion of hand grenade fragments from the face 60 years after injury. JAMA 2003;290:1317-1318.
51. Symonds RP, Mackay C, Morley P. The late effect of grenade fragments. J R Army Med Corps 1985;131:68-69. (Pubitemid 15225533)
52. Voigtlaender H. [Wandering of foreign bodies. (Grenate fragment in the common bile duct causing jaundice)]. Chirurg 1975;46:467-469.
53. Nuesslein TG, Teig N, Rieger CH. Pulmonary haemosiderosis in infants and children. Paediatr Respir Rev 2006;7:45-48. (Pubitemid 43210642)
54. Susarla SC, Fan LL. Diffuse alveolar hemorrhage syndromes in children. Curr Opin Pediatr 2007;19:314-320. (Pubitemid 46788119)
55. Verhoff MA, Muller KM. [Sideroelastosis of pulmonary vessels after welder dust exposure]. Pathologe 2000;21:229-233. (Pubitemid 30414675)
56. Hershko C, Link G, Konijn AM, Cabantchik ZI. Objectives and mechanism of iron chelation therapy. Ann N Y Acad Sci 2005;1054:124-135. (Pubitemid 43031017)